PD-1 INHIBITION CAN BE COMBINED WITH IL-12 IN SUBJECTS WITH RECURRENT GLIOBLASTOMA

被引：0

作者：

Chiocca, Ennio ^{[1
]}

Lukas, Rimas ^{[2
]}

Rao, Ganesh ^{[3
]}

Buck, Jill ^{[4
]}

Demars, Nathan ^{[4
]}

Smith, Amy ^{[4
]}

Miao, John ^{[4
]}

Zhou, John ^{[4
]}

Gelb, Arnold ^{[4
]}

Cooper, Laurence ^{[4
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA

[2] Northwestern Med, Chicago, IL USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Ziopharm Oncol Inc, Boston, MA USA

来源：

NEURO-ONCOLOGY | 2019年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ATIM-25

引用

页码：6 / 7

页数：2

共 50 条

[1] Controlled IL-12 in combination with a PD-1 inhibitor subjects with recurrent glioblastoma.
Chiocca, E. Antonio
Lukas, Rimas Vincas
Chen, Clark C.
Rao, Ganesh
Amidei, Christina
Buck, Jill Yannetti
Hadar, Nira
Demars, Nathan A.
Miao, John
Estupinan, Taylor
Loewy, John W.
Wang, Yunxia
Gelb, Arnold Bruce
Cooper, Laurence J. N.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[2] Evaluation of controlled IL-12 in combination with a PD-1 inhibitor in subjects with recurrent glioblastoma.
Chiocca, E. Antonio
Lukas, Rimas Vincas
Rao, Ganesh
Barrett, John A.
Buck, Jill Y.
Demars, Nathan
Smith, Amy
Miao, John
Zhou, Qiang
Gelb, Arnold Bruce
Cooper, Laurence
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[3] FINAL RESULTS OF CONTROLLED IL-12 MONOTHERAPY AND IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA
Lukas, Rimas
Oberheim-Bush, Nancy Ann
Cavaliere, Robert
Landolfi, Joseph
Yu, John S.
Chen, Clark
Cordova, Christine
Amidei, Christina
Buck, Jill Y.
Hadar, Nira
Demars, Nate
Miao, John
John, Loewy John
Estupinan, Taylor
Chadha, Kamal
Cooper, Laurence J. N.
Chiocca, E. Antonio
NEURO-ONCOLOGY, 2021, 23 : 54 - 54
[4] PHASE 2 TRIAL OF CONTROLLED IL-12 IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA (RGBM)
Lukas, Rimas
Chiocca, E. Antonio
Bush, Nancy Ann Oberheim
Landolfi, Joseph
Cavaliere, Robert
Yu, John
Kurz, Sylvia
Demars, Nathan
Buck, Jill
Hadar, Nira
Miao, John
Loewy, John
Wang, Yunxia
Gelb, Arnold
Cooper, Laurence
NEURO-ONCOLOGY, 2020, 22 : 39 - 39
[5] PD-1 peptide/IL-12 combination gene therapy for the treatment of melanoma
Heller, Loree
Shi, Guilan
Synowiec, Jody
Heller, Richard
CANCER RESEARCH, 2022, 82 (12)
[6] IL-12 and PD-1 peptide combination gene therapy for the treatment of melanoma
Heller, Loree C.
Shi, Guilan
Conniff, Amanda Sales
Singh, Julie
Mannarino, Samantha
Synowiec, Jody
Heller, Richard
MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (03):
[7] Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient
McCord, Matthew
Lukas, Rimas V.
Amidei, Christina
Demars, Nathan
Gelb, Arnold
Buck, Jill
Sachdev, Sean
Feldman, Alexander
Tate, Matthew
Dixit, Karan
Brat, Daniel J.
Jennings, Lawrence
Horbinski, Craig
NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
[8] INTRATUMORAL IL-12 DELIVERY VIA MESENCHYMAL STEM CELLS COMBINED WITH PD-1 BLOCKADE LEADS TO LONG-TERM ANTITUMOR IMMUNITY IN A MOUSE GLIOBLASTOMA MODEL
Ahn, Stephen
NEURO-ONCOLOGY, 2023, 25
[9] Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model
Park, Junseong
Park, Soon A.
Kim, Yoon-Seob
Kim, Dokyeong
Shin, Sun
Lee, Sug Hyung
Jeun, Sin-Soo
Chung, Yeun-Jun
Ahn, Stephen
BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
[10] Survival of subjects with recurrent glioblastoma receiving intratumoral administration of controlled IL-12 with limited exposure to dexamethasone.
Lukas, Rimas Vincas
Kurz, Sylvia Christine
Yu, John
Landolfi, Joseph C.
Rao, Ganesh
Amidei, Christina
Buck, Jill Yannetti
Hadar, Nira
Estupinan, Taylor
Miao, John
Loewy, John W.
Wang, Yunxia
Demars, Nathan A.
Gelb, Arnold Bruce
Laurence, J. N.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →